(R)-LSB
Lysergic acid 2-butyl amide
 
(8β)-N-[(2R)-Butan-2-yl]-6-methyl-9,10-didehydroergoline-8-carboxamide
 5937 ·  C20H25N3O ·  323.432
 InChI=1S/C20H25N3O/c1-4-12(2)22-20(24)14-8-16-15-6-5-7-17-19(15)13(10-21-17)9-18(16)23(3)11-14/h5-8,10,12,14,18,21H,4,9,11H2,1-3H3,(H,22,24)/t12-,14-,18-/m1/s1
 NYFSQPDQLFFBRA-RVZJWNSFSA-N This stereoisomer Any stereoisomer
 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C

Pfaff, RC; Huang, X; Marona-Lewicka, D; Oberlender, R; Nichols, DE. Lysergamides revisited. In Hallucinogens: An update. NIDA Research Monograph 146; Lin, GC; Glennon, RA, Eds., U.S. Department of Health and Human Services, National Institute of Health, U.S. Government Printing Office, Washington, DC, 1994; pp 52–73. 181 kB.

Nichols, DE. Structure-activity relationships of serotonin 5-HT2A agonists. WIREs Membr. Transp. Signal, 1 Sep 2012, 1 (5), 559-579. 573 kB. https://doi.org/10.1002/wmts.42 #17

Nichols, DE. LSD and its lysergamide cousins. Heffter Rev., 1 Jan 2001, 2 (6), 80–87. 265 kB.

LSD
N-Butyllysergamide
LSB · N-Butan-2-yllysergamide
LAMPA · LMP
MIPLA
l-LSD
d-iso-LSD
l-iso-LSD
(S)-LSB
16 November 2018 · Creative Commons BY-NC-SA ·